Binding and degradation of 251I-labelled insulin were studied in cultured foetal hepatocytes after exposure to the protein-synthesis inhibitors tunicamycin and cycloheximide. Tunicamycin (1 jug/ml) induced a steady decrease of insulin binding, which was decreased by 50% after 13 h. As the total number of binding sites per hepatocyte was 20000, the rate of the receptor degradation could not exceed 13 sites/min per hepatocyte. Cycloheximide (2.8 ug/ml) increased insulin binding by 30% within 6 h, an effect that persisted for up to 25 h. This drug had a specific inhibitory effect on the degradation of proteins prelabelled for lOh with ["Clglucosamine, without affecting the degradation of total proteins. Chronic exposure to 10nM-insulin neither decreased insulin binding nor modified the effect of the drugs. The absence of down-regulation of insulin receptors cannot be attributed to rapid receptor biosynthesis in foetal hepatocytes. Cellular insulin degradation, which is exclusively receptormediated, was determined by two different parameters. First, the rate of release of degraded insulin into the medium was 600 molecules/min per hepatocyte with 1 nM labelled hormone, and increased (preincubation with cycloheximide) or decreased (tunicamycin) as a function of the amount of cell-bound insulin. Secondly, the percentage of cell-bound insulin degraded was not changed by the presence of protein-synthesis inhibitors (25-30%). The stability of insulin degradation suggested that this process was dependent on long-life proteinase systems. Such differences in degradation rates and cycloheximide sensitivity imply that hormone-and receptor-degradation processes utilize distinct pathways.
The physiological effect of a variety of macromolecular substances in eukaryotic cells is accompanied by a cycle of events which involves ligand binding to cell surface sites, aggregation of occupied receptors and transfer of ligand-receptor complexes to an internal compartment by endocytosis. The receptor can be degraded or recycled back to the plasma membrane, whereas the fate of the internalized ligand depends essentially on its nature (Goldstein et al., 1979; Kaplan, 1981; Pearse & Bretscher, 1981) . This scheme applies to several polypeptide hormones, particularly to insulin (Gorden et al., 1980; Schlessinger, 1980; Goldfine, 1981; King & Cuatrecasas, 1981; Pastan & Willingham, 1981) . Insulin has been shown to be degraded in the cell, and its degradation is coupled to the binding of the hormone (Terris & Steiner, 1975) . Whether or not the fate of the receptor is linked to that of the ligand is debatable. Cultured foetal hepatocytes, where insulin degradation is known to be receptormediated (Plas & Desbuquois, 1982) , enable comparative studies of the effects of protein-synthesis inhibitors on insulin binding and degradation. The present study shows that the degradation pathways of insulin and its receptor are distinguishable by their differences in degradation rates and sensitivity to cycloheximide. It suggests that degradation of the receptor is not a prerequisite for active receptormediated insulin degradation and that the cell therefore has the possibility of reutilizing the insulin receptor.
Materials and methods

Cultureprocedure
Primary cultures were obtained from 18-day rat foetuses (Sprague-Dawley) as described previously lOpM-cortisol and 10mM-Hepes [4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid], pH7.3. It was supplemented daily with glucose (0.5 mg/dish). Experiments were performed after 2 or 3 days of culture -in the presence of cortisol, when the glycogenic effect of insulin is fully expressed (Plas & Nunez, 1976) .
Insulin-binding and -degradation studies
Measurements were performed as described previously (Desbuquois et al., 1974; Plas & Desbuquois, 1982) . Incubations of 1 nM-1251-labelled insulin with hepatocytes grown in monolayers (about 1.2 x 106 cells/dish) were performed at 370C and pH 7.3, in 2 ml of culture medium. On completion of the incubation, the medium was removed and the cells were washed with 4 x 2.5 ml of ice-cold Hanks solution. This washing step was performed within 12s. The cell-associated radioactivity was then extracted for 30min at 40C by two successive additions of 1 ml of 8.5 M-acetic acid containing 0.35 mM-bacitracin. The recovery of the radioactivity in the extract was about 95%. The small amount of radioactivity remaining was solubilized with lml of 0.5M-NaOH for 30min at 750C. The sum of radioactivity measured in this solution and in the acid extract represents the 'total binding'. Corrections were made for the non-specific association of 125I-labelled insulin to cells by performing parallel incubations in the presence of native insulin (3 pM). The acid-soluble labelled material recovered from the cells was allowed to dry at 230 C in a vacuum desiccator containing solid NaOH. The residue was dissolved in 1 ml of 0.1 M-HCl and the solution neutralized with 1 mM-Tris. The material was then tested for its ability to be precipitated by 10% (w/v) trichloroacetic acid. The soluble fraction represents the cell-bound insulin that was degraded. The effects of the protein-synthesis inhibitors on insulin binding and degradation were estimated as follows: after 2 days of culture, cells were incubated in the presence of either cycloheximide (2.8 pg/ml) or tunicamycin (1 jug/ml) or no inhibitor for various times. '25I-labelled insulin was then added to the medium and cultures were incubated for 30min. The amount of specifically bound insulin, the percentage of cell-bound insulin degraded and the amount of degraded insulin released in the medium were measured as described above.
Glycogenesis studies
Glycogen labelling in the presence of [14C]-glucose was determined as described previously (Plas et al., 1973 (1,ug/ml) were added at various times before labelling. Control cultures were grown without inhibitor. At zero time, the tracer was introduced in the medium and the cultures were stopped after 2 h of incubation. The radioactivity incorporated into proteins and the protein concentration were determined by the procedure described by Kitagawa (1980) . Protein degradation was studied by measuring either cell protein breakdown or release of proteindegradation products in the medium. Hepatocytes were prelabelled for 10h with [14Clleucine (0.05 pCi/ ml) or [3H]glucosamine (0.25,Ci/ml). Cultures were washed twice with unlabelled culture medium and incubated for 10min to allow the release of labelled precursors not incorporated into proteins (flushing). This medium was then replaced and drugs were added, or not, at this time (zero time of the experiment). Then, or after 6h of incubation in unlabelled medium, cultures were stopped and trichloroacetic acid-precipitable radioactivity incorporated into proteins was determined (Kitagawa, 1980) . Trichloroacetic acid-precipitable radioactivity was also measured in samples of the medium at various times.
Results
Effect of protein-synthesis inhibitors on insulin binding
The effect of cycloheximide (2.8,ug/ml) and tunicamycin (1 ug/ml) was tested from day 1 to day 3 of the culture. Insulin binding to hepatocytes was measured at various times of incubation after addition of the drug. The amount of specifically bound 125I-labelled insulin was determined after 30min at 370C, i.e. under steady-state binding conditions. In control cultures grown in the absence of drugs, the only modification was an occasional slight decrease of specific insulin binding during the 50h experimental period. After 5 h in the presence of cycloheximide, specific binding increased by 30% and remained steady for up to 25 h. Afterwards it declined, to reach 60% of the maximal value after a 50h preincubation (Fig. 1) . The increase in specific binding observed after a 8 h exposure to the drug was always present when measured at concentrations of 125I-labelled insulin ranging from 0.1 to 5 nm (results not shown). The presence of tunicamycin induced a significant decrease in insulin binding after 5 h of incubation. The time-course curve was used to determine the time needed to decrease specific binding by half, which was 13 h. 1983
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Degradation processes for insulin and its receptor Effect ofprotein-synthesis inhibitors and chronic exposure to insulin on insulin binding and degradation After preincubation of hepatocytes with cycloheximide (2.8 pg/ml) (a), tunicamycin (1 pg/ml) (b) or without drug (c) for various times indicated on the abscissa, 1 nM-1251I-labelled insulin was allowed to bind to cells for 30min at 370C. The amount of specifically bound labelled insulin and the percentage of cell-associated degraded labelled insulin were determined as described in the Materials and methods section. In another experiment, this protocol was repeated, except that preincubation was performed in the presence of lOnM native insulin (d). Then cultures were washed four times with insulin-free medium. In control cultures not preincubated with insulin, lOnM native hormone was added just before the washing step, to eliminate any possible carry-over effect of insulin. The specific binding of cultures preincubated with cycloheximide (K), cycloheximide and lOnM-insulin (0), tunicamycin (A), tunicamycin and lOnM-insulin (A), 10nM-insulin (0) or solvent alone (M), and the percentage of cell-associated insulin degraded (0) (Fig. 1) .
Chronic exposure to native insulin did not modify the percentage of cell-associated degradation, which remained constant (28-31%), and was again not changed in the presence of the drugs.
The '25I-labelled insulin that was degraded by the cells and released into the culture medium was determined at various times of incubation in the presence of 1 nm labelled hormone. The amount of trichloroacetic acid-soluble radioactivity in the medium increased linearly with time. This corresponded to a rate of 62.5 fmol of labelled insulin degraded/h per culture in the absence of inhibitors. When cells were preincubated with cycloheximide and tunicamycin for 15 h, this rate was increased by cycloheximide and decreased by tunicamycin (94.0 and 33.5 fmol/h culture respectively). The contrary effects of the drugs on the rate of insulin degradation were less marked when the amount of degraded insulin in the medium was expressed as a fraction of the corresponding amount of cell-bound hormone (Fig. 3) . Likewise, the insulin-degradation rate was proportional to the amount of cell-bound insulin when various concentrations of labelled hormone were used (results not shown). As it has been shown that the binding in foetal hepatocytes is saturable only above 10nM-insulin (Menuelle & Plas, 1981) , the degradation rate determined for 1 nM-insulin in the present study was not maximal.
The ability of the culture medium to degrade insulin was also tested. After preincubation of cultures with or without drugs, the medium was removed and incubated for 4 h in the presence of 1 nM-'25I-labelled insulin. Insulin degradation in the medium was not detectable even when the cells were preincubated with protein-synthesis inhibitors (Fig.  3) . The culture medium did not reveal any insulinproteolytic activity. The release of trichloroacetic acid-soluble radioactivity into the medium corresponded to the cell-mediated insulin-degradation rate, which for 1 nm labelled insulin was 600 molecules/min per hepatocyte in the absence of drug.
Protein-degradation processes infoetal hepatocytes
The degradation of proteins prelabelled for lOh with [14C]leucine or [3H]glucosamine was studied.
The decrease in radioactivity incorporated into proteins and the release of trichloroacetic acidsoluble radioactivity into the medium were measured over a 6 h incubation period after removal of the tracer. Cycloheximide was added, or not, at the end Time (h) Fig. 3 . Effect of protein-synthesis inhibitors on the appearance ofdegraded insulin in the medium Cell monolayers were preincubated for 15 h with either cycloheximide (2.8 pg/ml) or tunicamycin (1 ,ug/ml), or without drug. At the end of the preincubation period, 1 nM-'251-labelled insulin was added and the cells were incubated for various times indicated on the abscissa. Culture medium was then removed and the trichloroacetic acid-soluble radioactivity was determined. The amount of cellassociated labelled insulin was also measured. The appearance of insulin-degradation products in the medium is represented in (a), and these values are expressed as a fraction of the corresponding amounts of specifically cell-bound insulin in (b) (U, A, *). In parallel cultures, medium was removed at the end of the preincubation period and the insulin degradation was measured in the absence of cells (El, A, 0) Time (h) Fig. 4 . Effect ofcycloheximide on the release ofprotein-degradation products into the medium Cell monolayers were prelabelled for lOh with ["4Clleucine (0.05, uCi/ml) or [3Hlglucosamine (0.25,uCi/ml).
Cultures were then washed twice and flushed for 10min with unlabelled medium. This flushing medium was replaced by the unlabelled medium containing cycloheximide (2.8,ug/ml) or not (zero time of the experiment). Samples of the medium were taken at various times and trichloroacetic acid-soluble radioactivity was determined. The radioactivity so released in the presence of cycloheximide (0) or in its absence (0) is represented after prelabelling in (a) with ['4Clleucine and in (b) The release of trichloroacetic acid-soluble radioactivity in the medium was directly proportional to a loss of radioactivity in proteins. An initial rapid release followed by a slower rate was observed for both radioactive precursors (Fig. 4) . Cycloheximide did not modify this pattern in cells prelabelled with ['4Clleucine . As expected, this drug slowed the rate of release of degraded products from cells preincubated with [3Hlglucosamine. Under such experi-1983 mental conditions, cycloheximide had a specific inhibitory effect on glycoprotein degradation.
Discussion
Cultured foetal hepatocytes are suitable for correlative studies of insulin binding, insulin degradation and subsequent stimulation of glycogenesis (Menuelle & Plas, 1981; Plas & Desbuquois, 1982) . Insulin degradation is receptor-mediated in cultured foetal hepatocytes (Plas & Desbuquois, 1982) as well as in isolated adult hepatocytes (Terris & Steiner, 1975) . The close parallel observed between insulin degradation and insulin binding suggests a mandatory involvement of the insulin receptor in the degradation of the hormone. The present study used appropriate protein-synthesis inhibitors to distinguish receptor site degradation from degradation of the hormone within the cell.
Tunicamycin, an inhibitor of protein N-glycosylation (Takatsuki et al., 1975; Duksin & Bornstein, 1977) , induced a linear decrease in the specific binding of insulin: the half-time for the disappearance of binding was 13 h. As the tunicamycin-induced inhibition of [3Hlglucosamine incorporation into proteins showed a lag time of 3 h, this half-time is probably overestimated. These results suggest that protein N-glycosylation is required to produce functional insulin receptors. In 3T3-L1 adipocytes, the use of a heavy-isotope density-shift technique gave a half-life of 7.5 h for degradation of the insulin receptor, compared with a value of 9 h as determined by the tunicamycin-induced loss of the insulin-binding capacity (Rosen et al., 1979; Reed et al., 1981) . Cycloheximide has been shown to lengthen the half-life of insulin receptor degradation in these cells from 7.5 h to 25 h, thereby suggesting that the continued synthesis of a short-lived protein is required for insulin-receptor turnover (Reed et al., 1981) . In the present study, the half-time for the disappearance of insulin binding in the presence of cycloheximide was also lengthened (to 50h), and an early unexpected increase in binding (maximal after 5 h) was observed for all insulin concentrations in the range 0.1-5 nm. These results suggest an effect of cycloheximide on the rate of receptor degradation in cultured foetal hepatocytes. However, direct measurement of the turnover rate of the receptor will be necessary to confirm this interpretation.
Cycloheximide did not alter the degradation rate of total proteins in cultured foetal hepatocytes, yet it specifically inhibited the degradation of proteins prelabelled for lOh with [3Higlucosamine. As this inhibition was already obvious after 2h, the proteolytic system responsible for the degradation of glycoproteins responded rapidly to cycloheximide. This might be due to an inhibitory effect of the drug on the synthesis of a short-lived protein involved in the proteolytic process, but other possibilities, such as the release of some preformed proteinase from the cell (Hille et al., 1970) , cannot be excluded. The structure of the insulin receptor includes a carbohydrate moiety, and its glycoprotein nature is well documented (Jacobs et al., 1980; Hedo et al., 1981) . The insulin-receptor degradation participates in the general pattern of membrane glycoprotein turnover, which could depend on a proteolytic system sensitive to cycloheximide during the early exposure to the drug.
The degradation rate of insulin, as measured by the release of the degraded products into the medium, corresponded to about 600 molecules/min per hepatocyte for 1 nM-insulin. It was increased by 50%, or decreased by 45%, after 15 h exposure to cycloheximide or tunicamycin respectively. These variations seem to be related to the modifications in insulin binding, rather than to a direct effect of the drugs on insulin degradation, since they were no longer observed when insulin degradation was expressed as a fraction of cell-bound hormone. Furthermore, the percentage of cell-associated insulin degraded was unchanged in the presence of the drugs. These results are consistent with the linear dependence which holds between the insulindegradation rate and the concentration of insulin bound at steady state (Terris & Steiner, 1975 .
They confirm the receptor-mediated characteristic of insulin degradation in foetal hepatocytes (Plas & Desbuquois, 1982) . Besides, as insulin degradation is unaffected by protein-synthesis inhibitors, it must be under the dependence of long-life proteolytic systems. Several proteinases have been proposed for cellular insulin degradation, e.g. glutathione-insulin transhydrogenase (Ansorge et al., 1973; Varandani et al., 1975) and neutral glutathione-independent insulinase (Burghen et al., 1972; Duckworth et al., 1979; Goldstein & Livingston, 1981) . The most likely candidate in foetal hepatocytes should be sought among those proteinases that are not sensitive to cycloheximide and tunicamycin.
A clear glycogenic effect of insulin persisted after a 25 h incubation in the presence of tunicamycin, even though the insulin binding was decreased by 80%. In cultured foetal hepatocytes (Menuelle & Plas, 1981) , as in isolated soleus muscle (Le Marchand-Brustel et al., 1978) , insulin induces a half-maximal stimulation of glycogenesis when only a small fraction of the total receptor sites are occupied. Tunicamycin might therefore interfere with the synthesis of spare receptors. When cycloheximide was added together with insulin, the early glycogenic effect of insulin was maintained. This suggests that the insulin effect does not require protein synthesis de novo. However, a more prolonged incubation in the presence of the drug, which depressed both basal and insulin-stimulated glycoVol. 212 genesis, revealed that cycloheximide rapidly interferes with some step along the glycogen metabolic pathways. A specific inhibition of the glycogenic effect of insulin has been obtained in the presence of increasing chloroquine concentrations which in parallel inhibit cellular insulin degradation (Plas & Desbuquois, 1982) . This suggested that receptormediated insulin degradation, or some associated pathway, is functionally related to the insulin glycogenic effect in cultured foetal hepatocytes. Cycloheximide could be a useful tool with which to investigate this aspect, but under the conditions used in the present study its inhibitory effect does not appear to be specific to insulin-mediated events.
Chronic exposure of cultured foetal hepatocytes to native hormone does not induce a decrease in insulin binding (Menuelle & Plas, 1981 ; the present paper). The insulin-induced down-regulation of insulin receptors, first described in IM9 lymphocytes (Gavin et al., 1974) , has also been reported in cultured adult rat and chick hepatocytes (Blackard et al., 1978; Caro & Amatruda, 1980; Krupp & Lane, 1981) . It has been attributed to an insulininduced increase in the receptor-degradation rate in IM9 lymphocytes (Kosmakos & Roth, 1980; Kasuga et al., 1981) . Another mechanism has been implied in chick hepatocytes, namely the translocation of receptors from the cell surface to an intracellular compartment or to a sequestration of receptors in a state which is inaccessible to insulin (Krupp & Lane, 1981) . In foetal hepatocytes, the estimated half-life of insulin receptors was comparable with that reported in other systems, but chronic exposure to insulin did not reveal any down-regulation, even when protein synthesis was inhibited by cycloheximide or tunicamycin. Thus the absence of down-regulation cannot be explained by an exceptionally rapid rate of receptor synthesis (possibly insulin-induced), which is related to the foetal stage of the cells. These results suggest the existence of a pathway which is distinct from receptor biosynthesis de novo and which permits the maintenance of a constant pool of functional receptors in the plasma membrane.
Morphological evidence of internalization of insulin in the cell, after its binding to plasmamembrane receptors, has been obtained in isolated hepatocytes (Carpentier et al., 1979a) and intact liver (Bergeron et al., 1979; Carpentier et al., 1979b) , and the hormone has been shown to be associated with lysosomes, or closely related structures. Other studies suggest that the insulin receptor is internalized or translocated into the cell after its interaction with the hormone (Desbuquois et al., 1979; Hofmann et al., 1981; Desbuquois et al., 1982; Felhmann et al., 1982) . Receptor-mediated degradation of insulin is an active process in cultured foetal hepatocytes, where it represents 600 insulin molecules/min per hepatocyte for 1 nM-insulin. Maximal insulin binding, measured at a steady state at 370C in the presence of 30nM-insulin, corresponds to 20000 sites/hepatocyte (Menuelle & Plas, 1981) . As the half-life of the insulin receptor can be expected to be equal to 13 h in the presence of tunicamycin, the rate of receptor degradation cannot exceed 13 sites degraded/min per hepatocyte. The rate of insulin degradation was therefore much higher than that for receptor degradation, in the same way as in chick hepatocytes (Krupp & Lane, 1982) . This suggests that receptor site degradation is not required for the degradation of an insulin molecule that has interacted with its receptor, and thus implies the possible reutilization of the receptor. Furthermore, in cultured foetal hepatocytes, the proteolytic systems implicated in degradation of insulin and receptors differed in their sensitivity to cycloheximide. The degradation pathways of insulin and its receptor thus seem to be distinct. It is possible that the handling of insulin and its receptor depends on different enzymes, which may belong to a given subcellular compartment or be linked to a given single process, e.g. endocytosis.
